利培酮在治疗孤独症儿童行为问题中的作用

韦斌垣; 黄飞; 覃小田; 梁巧琦

PDF(987 KB)

中国当代儿科杂志 ›› 2011, Vol. 13 ›› Issue (3) : 216-218.

论著·临床研究

利培酮在治疗孤独症儿童行为问题中的作用

韦斌垣，黄飞，覃小田，梁巧琦

作者信息 +

Treatment of behavioral disorders by risperidone in children with autism

韦斌垣，黄飞，覃小田，梁巧琦

Author information +

文章历史 +

摘要

目的：研究利培酮在治疗孤独症儿童行为问题中的作用。方法：选取40例5～12岁具有行为问题的孤独症儿童，给予8周的利培酮治疗，在治疗前后进行临床疗效总评量表（CGI）和孤独症治疗评估量表(ATEC)评分，并观察利培酮治疗的不良反应。结果：利培酮治疗后第8周末的病情严重程度、ATEC总分均低于治疗前，且耐受性好；其中在ATEC评分中，除了社交评分在治疗前后无明显改变之外，言语、感知和行为评分均得到明显的改善。结论：利培酮可以显著地改善孤独症儿童的行为问题且具有良好的耐受性。

Abstract

OBJECTIVE: To study the effect of risperidone treatment on behavioral disorders in children with autism. METHODS: Forty children with behavioral disorders (aged from 5 to 12 years) were treated with risperidone for 8 weeks. The behavioral symptoms were evaluated by the Clinical Global Impression (CGI) and the Autism Treatment Evaluation Checklist (ATEC) before and after the treatment. The adverse events related to risperidone treatment were observed. RESULTS: The score of severity of illness and the ATEC total scores were significantly reduced 8 weeks after risperidone treatment. Besides the social intercourse ability, great improvements have been shown on the verbal communication, apperception and behavioural symptoms by the ATEC. No severe adverse events related to risperidone treatment were observed. CONCLUSIONS: Risperidone can significantly improve the behavioral disorders in children with autism and is well-tolerated.

导出引用

韦斌垣，黄飞，覃小田，梁巧琦. 利培酮在治疗孤独症儿童行为问题中的作用[J]. 中国当代儿科杂志. 2011, 13(3): 216-218

WEI Bin-Yuan, HUANG Fei, QIN Xiao-Tian, LIANG Qiao-Qi. Treatment of behavioral disorders by risperidone in children with autism[J]. Chinese Journal of Contemporary Pediatrics. 2011, 13(3): 216-218

中图分类号： R749.93

参考文献

［1］Liu T, Dhanasekaran SM, Jin H, Hu B, Tomlins SA, Chinnaiyan AM, et al. FIZZ1 stimulation of myofibroblast differentiation［J］. Am J Pathol, 2004, 164(4): 1315-1326.

［2］Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, et al. FIZZl, a novel cysteinerich secreted protein associated With pulmonary inflammation, defines a new gene family［J］. EMBO J, 2000, 19(15): 4046-4055.

［3］Axelson H. Notch signaling and cancer: emerging complexity［J］. Semin Cancer Biol, 2004, 14(5): 317-319.

［4］Katsuma S, Nishi K, Tanigawara K, Ikawa H, Shiojima S, Takagaki K, et al. Molecular monitoring of bleomycin-induced pulmonary fibrosis by cDNA microarray-based gene expression profiling［J］. Biochem Biophys Res Commun, 2001, 288(4): 747751.

［5］Liu T, Hu B, Choi YY, Chung M, Ullenbruch M, Yu H, et al. Notch1 signaling in FIZZ1 induction of myofibroblast differentiation［J］. Am J Pathol, 2009,174(5):1745-1755.

［6］Patel L, Buckels AC, Kinghom IJ, Murdock PR, Holbrook JD, Plumpton C, et al. Resistin is expressed in human macrophages and directly regulated by gamma activators［J］. Biochem Biophys Res Commu, 2003, 300(2):472-476.

［7］栾斌，黄先杰，乔俊英.SDF-1及 CXCR4在哮喘小鼠肺组织中的表达及布地奈德的干预作用［J］. 中国当代儿科杂志，2010，12（3）：215-218.

［8］An SS, Bai TR, Bates JH, Black JL, BrownRH, Brusasco V, et al. Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma［J］. Eur Respir J, 2007, 29(5): 834-860.

［9］Vignola AM , Mirabella F, Costanzo G, Di Giorgi R, Gjomarkaj M, Bellia V, et al. Airway remodeling in asthma［J］. Chest, 2003, 123(3 Suppl):417S-422S.

［10］Gerstmayer B, Küsters D, Gebel S, Müller T, Van Miert E, Hofmann K, et al. Identification of RELMgamma, a novel resistin-like molecule with a distinct expression pattern［J］．Genomics, 2003, 81(6): 588-595.

［11］Sweeney C, Morrow D, Birney YA, Coyle S, Hennessy C, Scheller A, et al. Notch 1 and 3 receptor signaling modulates vascular smooth muscle cell growth, apoptosis, and migration via a CBF-1/RBP-Jk dependent pathway［J］. FASEB J, 2004, 18(12): 1421-1423.

［12］Havrda MC, Johnson MJ, O′Neill CF, Liaw L. A novel mechanism of transcriptional repression of p27kip1 through Notch/HRT2 signaling in vascular smooth muscle cells［J］. Thromb Haemost, 2006, 96(3):361-370.

［13］Wang W, Prince CZ, Hu X, Pollman MJ. HRT1 modulates vascular smooth muscle cell proliferation and apoptosis［J］. Biochem Biophys Res Commun, 2003, 308(3): 596-601.

［14］Doi H, Iso T, Sato H, Yamazaki M, Matsui H, Tanaka T, et al. Jagged1-selective notch signaling induces smooth muscle differentiation via a RBP-Jkappa-dependent pathway［J］. J Biol Chem, 2006, 281(39): 28555-28564.

［15］Noseda M, Fu Y, Niessen K, Wong F, Chang L, McLean G, et al. Smooth muscle alpha-actin is a direct target of Notch/CSL［J］. Circ Res, 2006, 98(12):1468-1470.

［16］Proweller A, Pear WS, Parmacek MS. Notch signaling represses myocardin-induced smooth muscle cell differentiation［J］. Biol Chem, 2005, 280(10):8994-9004.